Startups
Click Therapeutics
New York, New York, United States · Boston, Massachusetts, United States
Click Therapeutics, Inc. develops prescription digital therapeutics using neuroscience, behavioral interventions, patient-centered software design and AI-enabled personalization. Founded in2012, it is headquartered in New York with a Boston office. Its products include the Otsuka collaboration Rejoyn for adjunctive major-depressive-disorder treatment, CT-132 for episodic migraine, acquired AspyreRx technology, and Boehringer Ingelheim collaboration Motivista (CT-155). FDA510(k) K254038 records Motivista clearance on July30,2026; the company announced it October5. Its indication is adjunctive treatment of negative schizophrenia symptoms in clinically stable adults under clinician care, not a general authorization of every pipeline program. Other programs remain at distinct development stages. Click SE extends its software platform to drug-related software and software-enhanced therapies. Published executives, board members and scientific advisers are represented separately; the October2026 SEC filing overrides a stale directory entry for resigned director Bruce Robertson. Financing records distinguish equity, notes, converted debt, loan proceeds, facility capacity and commercial collaboration funding. Better Therapeutics assets were acquired in2024; that asset purchase does not imply a legal merger or a disclosed acquisition price.
Founded 2012
Team
 Alex ZissonBoard member |
 Andrea Leonard-SegalScientific Advisor |
 Anthony CostelloBoard Member |
 Austin SpeierChief Strategy Officer |
 Barry FineScientific Advisor |
 Brian IacovielloScientific Advisor |
 Bruce LeuchterFounding Neuropsychiatrist |
 Bruce RobertsonFormer board member (resigned before October 1, 2026) |
 Cassandra SnipesHead of Science |
 Cris De LucaBoard Member |
 Daniel RimmHead of Product |
 David Benshoof KleinFounder & CEO · Board Member |
 David Friedman, MDBoard Member |
 Douglas LangaBoard Member |
 Gosia MachniewskaAssociate Design Director |
 Ioana MedreaScientific Advisor |
 Jeffrey BerkowitzBoard Member |
 Jihan GrantScientific Advisor |
 John KaneScientific Advisor |
 Joseph KvedarScientific Advisor |
Joshua SteinermanFounding Neuroscientist |
 Maria ForeroBoard Member |
 Maurizio FavaScientific Advisor |
 Merle DiamondScientific Advisor |
 Muzammil MansuriBoard Chair |
 Nicholas SchorkScientific Advisor |
 Patrick Tan (Click Therapeutics)Data Scientist |
 Randall StanickyChief Financial Officer |
 Rich DeNunzioChief Commercial Officer |
 Ritesh ManchandaHead of Engineering |
 Sarah JacksonHead of Business Development and Alliance Management |
 Stewart TepperScientific Advisor |
 Tarique CollinsChief Legal Officer |
 Viveca LivezeyChief Medical Advisor |